Study of Single-Ascending Doses of DS-6016a in Healthy Japanese Subjects

Summary

This study will assess the safety, tolerability, and pharmacokinetics of DS-6016a after subcutaneous injection in healthy Japanese participants.

Timeline

Start

2021-04-01

Primary completion

2021-12-24

Completion

2022-07-26

Publications

• Okita K, Furuie H, Kurata A, Owada Y, Yoshiba S, Furihata K, Oka T, Kashihara Y, Ishizuka H, Yoshihara K. First-In-Human Study to Assess the Pharmacokinetics and Safety of DS-6016a After Single Subcutaneous Injection in Healthy Japanese Adults. Clin Pharmacol Drug Dev. 2026 Jan;15(1):e70023. doi: 10.1002/cpdd.70023.

Drugs

Indications